Contract Research & Services
Clinical Trials

Integration of Molecular Biomarkers into Clinical Development

Published 27 May 2015 | By Quintiles

In the first of this two-part series, strategic drug developers Eric Groves, Jason Hill and Christopher Ung explain why biopharma cannot afford to ignore the growing surge of interest in biomarkers in oncology and discuss their critical role in the modern-day clinical development process.

Available Downloads

Integration of Molecular Biomarkers into Clinical Development